|
GB9801392D0
(en)
*
|
1998-01-22 |
1998-03-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9803411D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6194410B1
(en)
*
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
US6500865B1
(en)
|
1998-07-31 |
2002-12-31 |
Eli Lilly And Company |
Sulfonamide derivatives
|
|
GB9818914D0
(en)
*
|
1998-08-28 |
1998-10-21 |
Smithkline Beecham Plc |
Use
|
|
SE0001899D0
(sv)
|
2000-05-22 |
2000-05-22 |
Pharmacia & Upjohn Ab |
New compounds
|
|
US6586592B2
(en)
|
2000-06-20 |
2003-07-01 |
Pharmacia & Upjohn Company |
Bis-arylsulfones
|
|
PE20020063A1
(es)
|
2000-06-20 |
2002-01-30 |
Upjohn Co |
Bis-arilsulfonas como ligandos del receptor de 5-ht
|
|
SE0002739D0
(sv)
*
|
2000-07-21 |
2000-07-21 |
Pharmacia & Upjohn Ab |
New use
|
|
US6399617B1
(en)
*
|
2000-07-21 |
2002-06-04 |
Biovitrum Ab |
Use
|
|
GB0021450D0
(en)
*
|
2000-08-31 |
2000-10-18 |
Smithkline Beecham Plc |
Novel compounds
|
|
US7034029B2
(en)
|
2000-11-02 |
2006-04-25 |
Wyeth |
1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
|
|
US6849644B2
(en)
|
2000-11-21 |
2005-02-01 |
Smithkline Beecham P.L.C. |
Isoquinoline derivatives useful in the treatment of CNS disorders
|
|
US7718650B2
(en)
|
2001-05-11 |
2010-05-18 |
Biovitrum Ab |
Aryl sulfonamide compounds for treating obesity
|
|
MXPA03010232A
(es)
|
2001-05-11 |
2004-03-16 |
Biovitrum Ab |
Compuestos de arilsulfonamida, para el tratamiento de la obesidad, de la diabetes tipo ii y de trastornos del sistema nervioso central.
|
|
CN100457726C
(zh)
|
2001-06-11 |
2009-02-04 |
比奥维特罗姆股份公开公司 |
取代的磺酰胺化合物、其制备方法及其作为治疗cns疾病、肥胖和ⅱ型糖尿病的药物的应用
|
|
RU2268884C2
(ru)
|
2001-08-10 |
2006-01-27 |
Ф.Хоффманн-Ля Рош Аг |
Арилсульфонильные производные, обладающие сродством к рецептору 5-ht6, и способ их получения
|
|
RS44204A
(sr)
|
2001-11-22 |
2007-06-04 |
Biovitrum Ab., |
Inhibitori 11-beta- hidroksistereoidne dehidrogenaze tipa 1
|
|
EP1461327A1
(en)
*
|
2001-11-22 |
2004-09-29 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
IL161154A0
(en)
*
|
2001-11-22 |
2004-08-31 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
AU2007205749B2
(en)
*
|
2001-11-22 |
2009-04-23 |
Biovitrum Ab |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
|
|
EA200400707A1
(ru)
|
2001-11-22 |
2004-10-28 |
Биовитрум Аб |
Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
|
|
PL371344A1
(en)
*
|
2002-02-13 |
2005-06-13 |
Glaxo Group Limited |
Benzenesulfonamide derivatives as antipsychotic agents
|
|
WO2003068732A2
(en)
*
|
2002-02-13 |
2003-08-21 |
Glaxo Group Limited |
Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
|
|
US20050090485A1
(en)
*
|
2002-02-13 |
2005-04-28 |
Bromidge Steven M. |
7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders
|
|
GB0204720D0
(en)
*
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Novel use
|
|
AR039127A1
(es)
*
|
2002-03-27 |
2005-02-09 |
Glaxo Group Ltd |
Compuesto de quinolina, procedimiento para su preparacion, composicion farmaceutica que lo comprende y uso del mismo para la fabricacion de un medicamento
|
|
UA76877C2
(uk)
|
2002-05-13 |
2006-09-15 |
Ф.Хоффманн-Ля Рош Аг |
Похідні бензоксазину як 5-нт6 модулятори і їх застосування
|
|
AU2003248549B2
(en)
|
2002-05-24 |
2010-04-08 |
Millennium Pharmaceuticals, Inc. |
CCR9 inhibitors and methods of use thereof
|
|
JP4754821B2
(ja)
|
2002-06-20 |
2011-08-24 |
プロキシマゲン・リミテッド |
肥満症、ｉｉ型糖尿病およびｃｎｓ障害の治療に有用な新規化合物
|
|
EP1897881A3
(en)
|
2002-06-20 |
2009-03-18 |
Biovitrum AB (publ) |
Compounds useful for the treatment of obesity, type II diabetes and CNS disorders
|
|
JP2006505559A
(ja)
*
|
2002-10-18 |
2006-02-16 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６受容体親和性を持つ４−ピペラジニルベンゼンスルホニルインドール
|
|
US7741519B2
(en)
|
2007-04-23 |
2010-06-22 |
Chemocentryx, Inc. |
Bis-aryl sulfonamides
|
|
AU2003298661B2
(en)
|
2002-11-18 |
2007-05-10 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US20070021466A1
(en)
*
|
2002-11-18 |
2007-01-25 |
Solomon Ungashe |
CCR2 inhibitors and methods of use thereof
|
|
US7420055B2
(en)
|
2002-11-18 |
2008-09-02 |
Chemocentryx, Inc. |
Aryl sulfonamides
|
|
US7227035B2
(en)
*
|
2002-11-18 |
2007-06-05 |
Chemocentryx |
Bis-aryl sulfonamides
|
|
JP2006515341A
(ja)
*
|
2003-03-03 |
2006-05-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
５−ｈｔ６調節物質として使用するための２，５−および２，６−置換テトラヒドロイソキノリン
|
|
TWI289141B
(en)
*
|
2003-03-11 |
2007-11-01 |
Hoffmann La Roche F. Ag. |
Quinolinone derivatives and uses thereof
|
|
GB0305575D0
(en)
*
|
2003-03-11 |
2003-04-16 |
Glaxo Group Ltd |
Novel compounds
|
|
NZ544331A
(en)
|
2003-07-22 |
2010-03-26 |
Arena Pharm Inc |
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
US20050201965A1
(en)
*
|
2004-03-11 |
2005-09-15 |
The Procter & Gamble Company |
Personal cleansing compositions
|
|
JP2007537275A
(ja)
*
|
2004-05-12 |
2007-12-20 |
ケモセントリックス， インコーポレイテッド |
アリールスルホンアミド
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
EP1799306B1
(en)
|
2004-09-30 |
2011-02-23 |
F. Hoffmann-La Roche AG |
Compositions and methods for treating cognitive disorders
|
|
EP1695971A1
(en)
*
|
2004-12-30 |
2006-08-30 |
Laboratorios Del Dr. Esteve, S.A. |
Substituted phenyl-piperazine compounds, their preparation and use in medicaments
|
|
AR054044A1
(es)
*
|
2005-05-23 |
2007-05-30 |
Astrazeneca Ab |
Derivados de cromano y tetrahidronaftaleno como moduladores del receptor 5 - ht6; intermediarios en su preparacion; composiciones farmaceuticas que los contienen y su empelo en la fabricacion de medicamentos para el tratamiento de enfermedades del snc y de la obesidad.
|
|
AR054363A1
(es)
*
|
2005-05-23 |
2007-06-20 |
Astrazeneca Ab |
Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
|
|
US7998981B2
(en)
*
|
2005-08-12 |
2011-08-16 |
Suven Life Sciences Limited |
Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands
|
|
US7923566B2
(en)
|
2005-08-16 |
2011-04-12 |
Suven Life Sciences Limited |
Alternative process for the preparation of losartan
|
|
WO2007075895A2
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
|
WO2007133580A2
(en)
*
|
2006-05-09 |
2007-11-22 |
Zelos Therapeutics, Inc. |
Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
|
|
CN101553467B
(zh)
|
2007-01-08 |
2011-12-07 |
苏文生命科学有限公司 |
5-(杂环基)烷基-n-(芳基磺酰基)吲哚化合物及其作为5-ht6配体的用途
|
|
EP2120950B1
(en)
*
|
2007-03-21 |
2012-07-04 |
Glaxo Group Limited |
Use of quinoline derivatives in the treatment of pain
|
|
CL2008000986A1
(es)
|
2007-04-06 |
2008-10-17 |
Neurocrine Biosciences Inc |
COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
|
|
MX2009010828A
(es)
|
2007-04-06 |
2009-10-29 |
Neurocrine Biosciences Inc |
Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
|
|
AU2008246947B2
(en)
|
2007-05-03 |
2011-03-31 |
Suven Life Sciences Limited |
Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands
|
|
US7776877B2
(en)
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
|
CA2703157C
(en)
|
2007-10-26 |
2013-02-05 |
Suven Life Sciences Limited |
Amino arylsulfonamide compounds and their use as 5-ht6 ligands
|
|
EP2254564A1
(en)
|
2007-12-12 |
2010-12-01 |
Glaxo Group Limited |
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
|
|
EP2103596A1
(en)
|
2008-03-18 |
2009-09-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Process for the preparation of N-(phenylethyl) anilines salts and solvates thereof useful as serotonin 5-HT6 antagonists
|
|
WO2009123714A2
(en)
|
2008-04-02 |
2009-10-08 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
|
|
US20110034565A1
(en)
|
2008-04-18 |
2011-02-10 |
University College Dublin, National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
|
DE102008022221A1
(de)
|
2008-05-06 |
2009-11-12 |
Universität des Saarlandes |
Inhibitoren der humanen Aldosteronsynthase CYP11B2
|
|
US8318725B2
(en)
|
2008-09-17 |
2012-11-27 |
Suven Life Sciences Limited |
Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
|
|
MX2011002884A
(es)
|
2008-09-17 |
2011-04-21 |
Suven Life Sciences Ltd |
Compuestos de aril-sulfonamida-amina y su uso como ligandos de 5-ht6.
|
|
US9126946B2
(en)
|
2008-10-28 |
2015-09-08 |
Arena Pharmaceuticals, Inc. |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
|
|
UA100192C2
(en)
|
2008-11-11 |
2012-11-26 |
УАЙТ ЭлЭлСи |
1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
|
|
MX2011011515A
(es)
|
2009-04-30 |
2012-01-30 |
Abbott Gmbh & Co Kg |
Compuestos de bencensulfonanilida adecuados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
|
|
CA2759491A1
(en)
|
2009-04-30 |
2010-11-04 |
Abbott Gmbh & Co. Kg. |
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
CA2759482A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
|
|
US8343959B2
(en)
|
2009-04-30 |
2013-01-01 |
Abbott Gmbh & Co. Kg |
N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
AU2010276215A1
(en)
*
|
2009-07-21 |
2012-02-16 |
Auckland Uniservices Limited |
Heteroaryl benzamides, compositions and methods of use
|
|
US8541404B2
(en)
|
2009-11-09 |
2013-09-24 |
Elexopharm Gmbh |
Inhibitors of the human aldosterone synthase CYP11B2
|
|
MX2012007783A
(es)
|
2010-01-05 |
2012-10-03 |
Suven Life Sciences Ltd |
Compuestos sulfona que actuan como ligandos del receptor 5-ht6.
|
|
GB201002563D0
(en)
|
2010-02-15 |
2010-03-31 |
Cambridge Entpr Ltd |
Compounds
|
|
WO2012059431A1
(en)
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
|
|
WO2012059432A1
(en)
*
|
2010-11-01 |
2012-05-10 |
Abbott Gmbh & Co. Kg |
N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
|
|
US9708276B2
(en)
|
2011-10-12 |
2017-07-18 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
|
|
PE20142400A1
(es)
*
|
2012-04-27 |
2015-02-04 |
Glaxo Group Ltd |
Compuestos novedosos
|
|
CA2924527C
(en)
|
2013-09-20 |
2022-07-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Compounds for treating prostate cancer
|
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN104557664B
(zh)
*
|
2013-10-19 |
2020-01-21 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
|
KR20160068799A
(ko)
*
|
2013-10-25 |
2016-06-15 |
글락소스미스클라인 엘엘씨 |
신규 화합물
|
|
CN104725295B
(zh)
|
2013-12-20 |
2019-05-24 |
广东东阳光药业有限公司 |
芳杂环类衍生物及其在药物上的应用
|
|
EP3134392B1
(en)
*
|
2014-04-19 |
2019-01-02 |
Sunshine Lake Pharma Co., Ltd. |
Sulfonamide derivatives and pharmaceutical applications thereof
|
|
CN105367474A
(zh)
*
|
2014-08-12 |
2016-03-02 |
广东东阳光药业有限公司 |
吲哚啉类衍生物及其在药物上的应用
|
|
CN104529866A
(zh)
*
|
2014-12-12 |
2015-04-22 |
广东东阳光药业有限公司 |
吲哚类衍生物及其在药物上的应用
|
|
CN104496987B
(zh)
*
|
2014-12-12 |
2016-03-02 |
广东东阳光药业有限公司 |
取代杂环类化合物及其在药物上的应用
|
|
JP2018516992A
(ja)
|
2015-06-12 |
2018-06-28 |
アクソファント サイエンシーズ ゲーエムベーハーＡｘｏｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
|
|
CN108472285A
(zh)
|
2015-07-15 |
2018-08-31 |
阿速万科学有限责任公司 |
用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
|
|
HK1260897A1
(zh)
*
|
2015-08-21 |
2019-12-27 |
Portola Pharmaceuticals, Inc. |
使用四氢异喹啉小分子来结合并调节pcsk9的蛋白活性的组合物和方法
|
|
EP3337788A4
(en)
|
2015-08-21 |
2019-03-27 |
Portola Pharmaceuticals, Inc. |
PHENYLPIPERAZINE PROPROTEIN CONVERTASE SUBTILISIN / -KEXIN TYPE 9 P (CSK9) MODULATORS AND THEIR USE
|
|
WO2017034994A1
(en)
|
2015-08-21 |
2017-03-02 |
Portola Pharmaceuticals, Inc. |
Composition and methods of use of novel phenylalanine small organic compounds to directly modulate pcsk9 protein activity
|
|
WO2017147328A1
(en)
|
2016-02-23 |
2017-08-31 |
Portola Pharmaceuticals, Inc. |
Compounds for binding proprotein convertase subtilisin/kexin type 9 (pcsk9)
|
|
US10980806B2
(en)
|
2016-03-24 |
2021-04-20 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
|
CN111517963A
(zh)
*
|
2020-06-02 |
2020-08-11 |
杭州福莱蒽特科技有限公司 |
环保型2，6-二氯-4-硝基苯胺的制备方法
|
|
US12115154B2
(en)
|
2020-12-16 |
2024-10-15 |
Srx Cardio, Llc |
Compounds for the modulation of proprotein convertase subtilisin/kexin type 9 (PCSK9)
|